0001694665-23-000117.txt : 20230712 0001694665-23-000117.hdr.sgml : 20230712 20230712160555 ACCESSION NUMBER: 0001694665-23-000117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230711 FILED AS OF DATE: 20230712 DATE AS OF CHANGE: 20230712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Jeffrey R. CENTRAL INDEX KEY: 0001469098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 231084273 BUSINESS ADDRESS: BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1689192346.xml FORM 4 X0407 4 2023-07-11 0 0001694665 Evelo Biosciences, Inc. EVLO 0001469098 Moore Jeffrey R. C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 1 0 0 0 0 Stock Option (Right to Buy) 3.38 2023-07-11 4 A 0 2000 0 A 2033-07-11 Common Stock 2000 2000 D The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years. On June 29, 2023, the Issuer effected a 1-for-20 reverse stock split. The share counts herein have been adjusted to reflect the reverse stock split. /s/ Marella Thorell, Attorney-in-Fact for Jeffrey R. Moore 2023-07-12